Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Heptavalent Pneumococcal Conjugate Vaccine"" wg kryterium: Temat


Tytuł:
Divergent serotype replacement trends and increasing diversity in pneumococcal disease in high income settings reduce the benefit of expanding vaccine valency.
Autorzy:
Løchen A; Department of Infectious Disease Epidemiology, School of Public Health, Imperial College, London, UK.; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, Norfolk Place, London, W2 1PG, UK.
Croucher NJ; Department of Infectious Disease Epidemiology, School of Public Health, Imperial College, London, UK. .; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, Norfolk Place, London, W2 1PG, UK. .
Anderson RM; Department of Infectious Disease Epidemiology, School of Public Health, Imperial College, London, UK.; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, Norfolk Place, London, W2 1PG, UK.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Nov 04; Vol. 10 (1), pp. 18977. Date of Electronic Publication: 2020 Nov 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Heptavalent Pneumococcal Conjugate Vaccine/*administration & dosage
Pneumococcal Infections/*epidemiology
Streptococcus pneumoniae/*classification
Adult ; Australia/epidemiology ; Europe/epidemiology ; Female ; Heptavalent Pneumococcal Conjugate Vaccine/immunology ; Humans ; Incidence ; Infant ; Male ; North America/epidemiology ; Pneumococcal Infections/microbiology ; Pneumococcal Infections/prevention & control ; Pneumococcal Vaccines/administration & dosage ; Pneumococcal Vaccines/immunology ; Serogroup ; Streptococcus pneumoniae/immunology ; Streptococcus pneumoniae/isolation & purification
Czasopismo naukowe
Tytuł:
Pneumococcal conjugate vaccines decrease community-acquired alveolar pneumonia with and without pleural effusion in children <60 months in Southern Israel, 2002-2016.
Autorzy:
Triadou D; The Pediatric Infectious Disease Unit, Soroka University Medical Center, Beer-Sheva, Israel.; The Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Givon-Lavi N; The Pediatric Infectious Disease Unit, Soroka University Medical Center, Beer-Sheva, Israel.; The Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Greenberg D; The Pediatric Infectious Disease Unit, Soroka University Medical Center, Beer-Sheva, Israel.; The Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Ben-Shimol S; The Pediatric Infectious Disease Unit, Soroka University Medical Center, Beer-Sheva, Israel.; The Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Pokaż więcej
Źródło:
Infectious diseases (London, England) [Infect Dis (Lond)] 2020 Mar; Vol. 52 (3), pp. 186-195. Date of Electronic Publication: 2019 Nov 27.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Heptavalent Pneumococcal Conjugate Vaccine*
Community-Acquired Infections/*epidemiology
Community-Acquired Infections/*prevention & control
Pneumonia, Pneumococcal/*epidemiology
Pneumonia, Pneumococcal/*prevention & control
Arabs/statistics & numerical data ; Child, Preschool ; Community-Acquired Infections/complications ; Humans ; Immunologic Factors ; Incidence ; Infant ; Influenza A virus/isolation & purification ; Influenza, Human/epidemiology ; Israel/epidemiology ; Jews/statistics & numerical data ; Nose/virology ; Pleural Effusion/microbiology ; Prospective Studies ; Pulmonary Alveoli ; Respiratory Syncytial Virus Infections/epidemiology ; Respiratory Syncytial Viruses/isolation & purification
Czasopismo naukowe
Tytuł:
Estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales: A modelling study.
Autorzy:
Choi YH; Statistics, Modelling and Economics Department, Data and Analytical Sciences, National Infection Service, Public Health England, London, United Kingdom.
Andrews N; Statistics, Modelling and Economics Department, Data and Analytical Sciences, National Infection Service, Public Health England, London, United Kingdom.
Miller E; Immunisation and Countermeasures Division, National Infection Service, Public Health England, London, United Kingdom.
Pokaż więcej
Źródło:
PLoS medicine [PLoS Med] 2019 Jul 03; Vol. 16 (7), pp. e1002845. Date of Electronic Publication: 2019 Jul 03 (Print Publication: 2019).
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Immunization Programs*
Immunization Schedule*
Immunogenicity, Vaccine*
Models, Theoretical*
Vaccination*
Community-Acquired Infections/*prevention & control
Heptavalent Pneumococcal Conjugate Vaccine/*administration & dosage
Pneumococcal Infections/*prevention & control
Pneumococcal Vaccines/*administration & dosage
Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Community-Acquired Infections/immunology ; Community-Acquired Infections/mortality ; Community-Acquired Infections/transmission ; England/epidemiology ; Heptavalent Pneumococcal Conjugate Vaccine/immunology ; Humans ; Immunity, Herd ; Incidence ; Infant ; Infant, Newborn ; Middle Aged ; Pneumococcal Infections/immunology ; Pneumococcal Infections/mortality ; Pneumococcal Infections/transmission ; Pneumococcal Vaccines/immunology ; Prevalence ; Program Evaluation ; Time Factors ; Wales/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł:
Incidence of invasive pneumococcal disease in children with commercial insurance or Medicaid coverage in the United States before and after the introduction of 7- and 13-valent pneumococcal conjugate vaccines during 1998-2018.
Autorzy:
Hu T; Merck & Co., Inc., 126 East Lincoln Ave, P.O. Box 2000, Rahway, NJ, 07065, USA.
Song Y; Analysis Group, Inc., 111 Huntington Avenue 14th Floor, Boston, MA, 02199, USA.
Done N; Analysis Group, Inc., 111 Huntington Avenue 14th Floor, Boston, MA, 02199, USA.
Liu Q; Analysis Group, Inc., 111 Huntington Avenue 14th Floor, Boston, MA, 02199, USA.
Sarpong EM; Merck & Co., Inc., 126 East Lincoln Ave, P.O. Box 2000, Rahway, NJ, 07065, USA.
Lemus-Wirtz E; Analysis Group, Inc., 111 Huntington Avenue 14th Floor, Boston, MA, 02199, USA.
Signorovitch J; Analysis Group, Inc., 111 Huntington Avenue 14th Floor, Boston, MA, 02199, USA.
Mohanty S; Merck & Co., Inc., 126 East Lincoln Ave, P.O. Box 2000, Rahway, NJ, 07065, USA. .
Weiss T; Merck & Co., Inc., 126 East Lincoln Ave, P.O. Box 2000, Rahway, NJ, 07065, USA.
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2022 Sep 05; Vol. 22 (1), pp. 1677. Date of Electronic Publication: 2022 Sep 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Bacteremia*/epidemiology
Insurance*
Pneumococcal Infections*/epidemiology
Pneumococcal Infections*/prevention & control
Child ; Heptavalent Pneumococcal Conjugate Vaccine ; Humans ; Incidence ; Infant ; Medicaid ; Pneumococcal Vaccines/therapeutic use ; Serogroup ; United States/epidemiology ; Vaccines, Conjugate
Czasopismo naukowe
Tytuł:
Impact of PCV7 vaccination on nasopharyngeal carriage and antimicrobial resistance among children in Turkey.
Autorzy:
Kaya Gursoy B; Department of Pediatrics, Faculty of Medicine, Gazi University Ankara, Turkey. .
Beyazova U; Department of Pediatrics, Faculty of Medicine, Gazi University Ankara, Turkey. .
Oguz MM; Department of Pediatrics, Dr. Sami Ulus Maternity and Children's Health and Diseases Training and Research Hospital, Ankara, Turkey. .
Demirel F; Department of Microbiology, Faculty of Medicine, Gazi University Ankara, Turkey. .
Ozkan S; Department of Public Health, Faculty of Medicine, Gazi University Ankara, Turkey. .
Sultan N; Department of Microbiology, Faculty of Medicine, Gazi University Ankara, Turkey. .
Nar Otgun S; National Respiratory Pathogens Reference Laboratory, Public Health Institution of Turkey, Ankara, Turkey. .
Pokaż więcej
Źródło:
Journal of infection in developing countries [J Infect Dev Ctries] 2019 Mar 31; Vol. 13 (3), pp. 227-232. Date of Electronic Publication: 2019 Mar 31.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Drug Resistance, Bacterial*
Carrier State/*microbiology
Heptavalent Pneumococcal Conjugate Vaccine/*immunology
Nasopharynx/*microbiology
Pneumococcal Infections/*prevention & control
Streptococcus pneumoniae/*classification
Streptococcus pneumoniae/*isolation & purification
Carrier State/epidemiology ; Female ; Follow-Up Studies ; Heptavalent Pneumococcal Conjugate Vaccine/administration & dosage ; Hospitals, Pediatric ; Humans ; Infant ; Male ; Microbial Sensitivity Tests ; Pneumococcal Infections/epidemiology ; Pneumococcal Infections/microbiology ; Prevalence ; Serogroup ; Serotyping ; Tertiary Care Centers ; Turkey
Czasopismo naukowe
Tytuł:
Genome-wide analysis of Streptococcus pneumoniae serogroup 19 in the decade after the introduction of pneumococcal conjugate vaccines in Australia.
Autorzy:
Rockett RJ; Centre for Infectious Diseases and Microbiology - Public Health, Westmead Hospital, Westmead, 2145, Australia. .; Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Camperdown, 2050, Australia. .
Oftadeh S; Centre for Infectious Diseases and Microbiology - Public Health, Westmead Hospital, Westmead, 2145, Australia.; NSW Pneumococcal Reference Laboratory, Institute of Clinical Pathology and Medical Research - NSW Health Pathology, Westmead, 2145, Australia.
Bachmann NL; Centenary Institute, The University of Sydney, Camperdown, 2050, Australia.
Timms VJ; Centre for Infectious Diseases and Microbiology - Public Health, Westmead Hospital, Westmead, 2145, Australia.
Kong F; NSW Pneumococcal Reference Laboratory, Institute of Clinical Pathology and Medical Research - NSW Health Pathology, Westmead, 2145, Australia.
Gilbert GL; Centre for Infectious Diseases and Microbiology - Public Health, Westmead Hospital, Westmead, 2145, Australia.; Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Camperdown, 2050, Australia.
Sintchenko V; Centre for Infectious Diseases and Microbiology - Public Health, Westmead Hospital, Westmead, 2145, Australia.; NSW Pneumococcal Reference Laboratory, Institute of Clinical Pathology and Medical Research - NSW Health Pathology, Westmead, 2145, Australia.; Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Camperdown, 2050, Australia.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2018 Nov 16; Vol. 8 (1), pp. 16969. Date of Electronic Publication: 2018 Nov 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Heptavalent Pneumococcal Conjugate Vaccine/*immunology
Pneumococcal Infections/*immunology
Pneumococcal Vaccines/*immunology
Streptococcus pneumoniae/*immunology
Child, Preschool ; Genome, Bacterial/genetics ; Genome-Wide Association Study ; Heptavalent Pneumococcal Conjugate Vaccine/administration & dosage ; Humans ; Immunization Schedule ; Incidence ; Infant ; Multilocus Sequence Typing ; New South Wales/epidemiology ; Phylogeny ; Pneumococcal Infections/epidemiology ; Pneumococcal Infections/prevention & control ; Pneumococcal Vaccines/administration & dosage ; Pneumococcal Vaccines/classification ; Serogroup ; Streptococcus pneumoniae/classification ; Streptococcus pneumoniae/genetics ; Vaccines, Conjugate/administration & dosage ; Vaccines, Conjugate/immunology
Czasopismo naukowe
Tytuł:
Use of weighted multivariate estimates in trials of multi-serotype vaccines to simplify interpretation of treatment differences.
Autorzy:
Voysey M; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; National Institute for Health Research Oxford Biomedical Research Centre, Oxford, United Kingdom.
Perera R; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
Shrestha S; Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal.
Thorson S; Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal.
Fanshawe TR; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2018 Apr 27; Vol. 13 (4), pp. e0196200. Date of Electronic Publication: 2018 Apr 27 (Print Publication: 2018).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Bacterial/*analysis
Heptavalent Pneumococcal Conjugate Vaccine/*administration & dosage
Pneumococcal Infections/*prevention & control
Streptococcus pneumoniae/*immunology
Adolescent ; Bangladesh ; Child ; Child, Preschool ; Drug Administration Schedule ; Female ; Heptavalent Pneumococcal Conjugate Vaccine/immunology ; Humans ; Infant ; Male ; Nepal ; Pakistan ; Pneumococcal Infections/immunology ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
The Incidence of Pediatric Invasive Bacterial Diseases in Nippon Medical School Chiba Hokusoh Hospital before and after the Introduction of Conjugate Vaccines.
Autorzy:
Sano T; Department of Pediatrics, Nippon Medical School Chiba Hokusoh Hospital.
Suzuki T; Department of Pediatrics, Nippon Medical School Chiba Hokusoh Hospital.
Nishigori A; Department of Pediatrics, Nippon Medical School Chiba Hokusoh Hospital.
Miyatake C; Department of Pediatrics, Nippon Medical School Chiba Hokusoh Hospital.
Koizumi S; Department of Pediatrics, Nippon Medical School Chiba Hokusoh Hospital.
Kaizu K; Department of Pediatrics, Nippon Medical School Chiba Hokusoh Hospital.
Fujita A; Department of Pediatrics, Nippon Medical School Chiba Hokusoh Hospital.
Kamisago M; Department of Pediatrics, Nippon Medical School Chiba Hokusoh Hospital.
Chang B; Department of Bacteriology I, National Institute of Infectious Diseases.
Ishiwada N; Department of Infectious Diseases, Medical Mycology Research Center, Chiba University.
Asano T; Department of Pediatrics, Nippon Medical School Chiba Hokusoh Hospital.
Pokaż więcej
Źródło:
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi [J Nippon Med Sch] 2018; Vol. 85 (1), pp. 34-38.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Haemophilus Vaccines*
Haemophilus influenzae*
Heptavalent Pneumococcal Conjugate Vaccine*
Vaccines, Conjugate*
Haemophilus Infections/*epidemiology
Haemophilus Infections/*prevention & control
Hospitals, University/*statistics & numerical data
Pneumococcal Infections/*epidemiology
Anti-Bacterial Agents/pharmacology ; Child ; Child, Preschool ; Drug Resistance, Bacterial ; Haemophilus Infections/microbiology ; Humans ; Incidence ; Infant ; Japan/epidemiology ; Male ; Pneumococcal Infections/microbiology ; Pneumococcal Infections/prevention & control ; Streptococcus pneumoniae/drug effects ; Streptococcus pneumoniae/genetics ; Streptococcus pneumoniae/isolation & purification
Czasopismo naukowe
Tytuł:
Longitudinal multiparameter single-cell analysis of macaques immunized with pneumococcal protein-conjugated or unconjugated polysaccharide vaccines reveals distinct antigen specific memory B cell repertoires.
Autorzy:
Jia B; Koch Institute for Integrative Cancer Research, Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
McNeil LK; Pfizer Vaccine Research and Early Development, Pearl River, New York, United States of America.
Dupont CD; Koch Institute for Integrative Cancer Research, Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
Tsioris K; Koch Institute for Integrative Cancer Research, Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
Barry RM; Koch Institute for Integrative Cancer Research, Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
Scully IL; Pfizer Vaccine Research and Early Development, Pearl River, New York, United States of America.
Ogunniyi AO; Koch Institute for Integrative Cancer Research, Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
Gonzalez C; Koch Institute for Integrative Cancer Research, Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
Pride MW; Pfizer Vaccine Research and Early Development, Pearl River, New York, United States of America.
Gierahn TM; Koch Institute for Integrative Cancer Research, Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
Liberator PA; Pfizer Vaccine Research and Early Development, Pearl River, New York, United States of America.
Jansen KU; Pfizer Vaccine Research and Early Development, Pearl River, New York, United States of America.
Love JC; Koch Institute for Integrative Cancer Research, Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.; The Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2017 Sep 14; Vol. 12 (9), pp. e0183738. Date of Electronic Publication: 2017 Sep 14 (Print Publication: 2017).
Typ publikacji:
Journal Article
MeSH Terms:
B-Lymphocytes/*metabolism
Heptavalent Pneumococcal Conjugate Vaccine/*administration & dosage
Macaca/*immunology
Pneumococcal Vaccines/*administration & dosage
Animals ; Antibodies, Bacterial/immunology ; Heptavalent Pneumococcal Conjugate Vaccine/immunology ; Immunization, Secondary ; Immunologic Memory ; Pneumococcal Vaccines/immunology ; Single-Cell Analysis ; Streptococcus pneumoniae/immunology
Czasopismo naukowe
Tytuł:
Effect of previous vaccination with pneumococcal conjugate vaccine on pneumococcal polysaccharide vaccine antibody responses.
Autorzy:
Schaballie H; Department of Pediatrics, University Hospitals Leuven.; Department of Microbiology and Immunology, KU Leuven - University of Leuven.
Wuyts G; Department of Microbiology and Immunology, KU Leuven - University of Leuven.
Dillaerts D; Department of Microbiology and Immunology, KU Leuven - University of Leuven.
Frans G; Department of Microbiology and Immunology, KU Leuven - University of Leuven.; Department of Laboratory Medicine, University Hospitals Leuven, Belgium.
Moens L; Department of Microbiology and Immunology, KU Leuven - University of Leuven.
Proesmans M; Department of Pediatrics, University Hospitals Leuven.
Vermeulen F; Department of Pediatrics, University Hospitals Leuven.
De Boeck K; Department of Pediatrics, University Hospitals Leuven.
Meyts I; Department of Pediatrics, University Hospitals Leuven.; Department of Microbiology and Immunology, KU Leuven - University of Leuven.
Bossuyt X; Department of Microbiology and Immunology, KU Leuven - University of Leuven.; Department of Laboratory Medicine, University Hospitals Leuven, Belgium.
Pokaż więcej
Źródło:
Clinical and experimental immunology [Clin Exp Immunol] 2016 Aug; Vol. 185 (2), pp. 180-9. Date of Electronic Publication: 2016 May 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Bacterial/*blood
Heptavalent Pneumococcal Conjugate Vaccine/*immunology
Pneumococcal Vaccines/*immunology
Polysaccharides, Bacterial/*immunology
Streptococcus pneumoniae/*immunology
Vaccines, Conjugate/*immunology
Adolescent ; Child ; Child, Preschool ; Female ; Heptavalent Pneumococcal Conjugate Vaccine/administration & dosage ; Humans ; Immunoglobulin G/blood ; Male ; Pneumococcal Infections/immunology ; Pneumococcal Infections/microbiology ; Pneumococcal Vaccines/administration & dosage ; Retrospective Studies ; Serogroup ; Time Factors ; Vaccination ; Vaccines, Conjugate/administration & dosage
Czasopismo naukowe
Tytuł:
Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease After Introduction Into Routine Pediatric Use.
Autorzy:
Baxter R; Vaccine Study Center, Kaiser Permanente, Oakland, California, USA.
Aukes L; Vaccine Study Center, Kaiser Permanente, Oakland, California, USA.
Pelton SI; Department of Pediatrics, Boston University School of Public Health, Boston, Massachusetts, USA.; Department of Pediatrics, Boston Medical Center, Boston, Massachusetts, USA.
Yee A; Vaccine Study Center, Kaiser Permanente, Oakland, California, USA.
Klein NP; Vaccine Study Center, Kaiser Permanente, Oakland, California, USA.
Gruber WC; Vaccine Clinical Research and Development, Pfizer Inc, Pearl River, New York, USA.
Scott DA; Vaccine Clinical Research and Development, Pfizer Inc, Collegeville, Pennsylvania, USA.
Center KJ; Vaccine Clinical Research and Development, Pfizer Inc, Collegeville, Pennsylvania, USA.
Pokaż więcej
Źródło:
Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2021 Mar 26; Vol. 10 (2), pp. 141-150.
Typ publikacji:
Journal Article
MeSH Terms:
Pneumococcal Infections*/epidemiology
Pneumococcal Infections*/prevention & control
Child ; Heptavalent Pneumococcal Conjugate Vaccine ; Humans ; Incidence ; Infant ; Prospective Studies ; Streptococcus pneumoniae ; Vaccines, Conjugate
Czasopismo naukowe
Tytuł:
IgM, IgA and IgG response to conjugate polysaccharides in children with recurrent respiratory infections.
Autorzy:
Cavaliere FM; Department of Molecular Medicine, Sapienza University, Rome, Italy.
Graziani S; Pediatric Immunopathology and Allergology Unit, Policlinico Tor Vergata, University of Rome Tor Vergata, Rome, Italy.
Del Duca E; Pediatric Immunopathology and Allergology Unit, Policlinico Tor Vergata, University of Rome Tor Vergata, Rome, Italy.
Bilotta C; Department of Molecular Medicine, Sapienza University, Rome, Italy.
Sgrulletti M; Pediatric Immunopathology and Allergology Unit, Policlinico Tor Vergata, University of Rome Tor Vergata, Rome, Italy.
Quinti I; Department of Molecular Medicine, Sapienza University, Rome, Italy.
Moschese V; Pediatric Immunopathology and Allergology Unit, Policlinico Tor Vergata, University of Rome Tor Vergata, Rome, Italy.
Pokaż więcej
Źródło:
Scandinavian journal of immunology [Scand J Immunol] 2021 Jan; Vol. 93 (1), pp. e12955. Date of Electronic Publication: 2020 Aug 27.
Typ publikacji:
Letter
MeSH Terms:
Antibodies, Bacterial/*blood
Heptavalent Pneumococcal Conjugate Vaccine/*immunology
Immunoglobulin A/*blood
Immunoglobulin G/*blood
Immunoglobulin M/*blood
Antigens, Bacterial/immunology ; Child ; Child, Preschool ; Humans ; Immunoglobulin A/immunology ; Immunoglobulin G/immunology ; Immunoglobulin M/immunology ; Polysaccharides, Bacterial/immunology ; Respiratory Tract Infections/immunology ; Respiratory Tract Infections/microbiology
Opinia redakcyjna
Tytuł:
Streptococcus pneumoniae colonisation in children and adolescents with asthma: impact of the heptavalent pneumococcal conjugate vaccine and evaluation of potential effect of thirteen-valent pneumococcal conjugate vaccine.
Autorzy:
Esposito S; Pediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Commenda 9, Milan, 20122, Italy. .
Terranova L; Pediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Commenda 9, Milan, 20122, Italy. .
Patria MF; Pediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Commenda 9, Milan, 20122, Italy. .
Marseglia GL; Pediatric Clinic, University of Pavia, IRCCS Policlinico 'S. Matteo' Foundation, Pavia, Italy. .
Miraglia del Giudice M; Pediatric Clinic, II Naples University, Naples, Italy. .
Bodini A; Pediatric Clinic, University of Verona, Verona, Italy. .
Martelli A; Pediatric Unit, Garbagnate Hospital, Garbagnate, Italy. .
Baraldi E; Pediatric Clinic, University of Padua, Padua, Italy. .
Mazzina O; Allergology Unit, IRCCS Bambino Gesù Hospital, Rome, Italy. .
Tagliabue C; Pediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Commenda 9, Milan, 20122, Italy. .
Licari A; Pediatric Clinic, University of Pavia, IRCCS Policlinico 'S. Matteo' Foundation, Pavia, Italy. .
Ierardi V; Pediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Commenda 9, Milan, 20122, Italy. .
Lelii M; Pediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Commenda 9, Milan, 20122, Italy. .
Principi N; Pediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Commenda 9, Milan, 20122, Italy. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2016 Jan 12; Vol. 16, pp. 12. Date of Electronic Publication: 2016 Jan 12.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Asthma/*immunology
Heptavalent Pneumococcal Conjugate Vaccine/*immunology
Streptococcus pneumoniae/*growth & development
Adolescent ; Asthma/microbiology ; Asthma/prevention & control ; Child ; Child, Preschool ; Drug Evaluation ; Female ; Heptavalent Pneumococcal Conjugate Vaccine/administration & dosage ; Humans ; Male ; Nasopharynx/microbiology ; Pneumococcal Infections/immunology ; Pneumococcal Infections/microbiology ; Pneumococcal Infections/prevention & control ; Streptococcus pneumoniae/genetics ; Streptococcus pneumoniae/isolation & purification ; Streptococcus pneumoniae/physiology ; Vaccines, Conjugate/administration & dosage ; Vaccines, Conjugate/immunology
Czasopismo naukowe
Tytuł:
Epidemiology of Community-Acquired Pneumonia Hospitalizations and Associated Complications Before and After the Implementation of the Heptavalent Pneumococcal Conjugate Vaccine in Athens, Greece.
Autorzy:
Lagousi T; First University Department of Pediatrics, 'Aghia Sophia' Children's Hospital, National and Kapodistrian University of Athens School of Medicine, Greece.
Papadatou I; First University Department of Pediatrics, 'Aghia Sophia' Children's Hospital, National and Kapodistrian University of Athens School of Medicine, Greece.
Kopsidas I; First University Department of Pediatrics, 'Aghia Sophia' Children's Hospital, National and Kapodistrian University of Athens School of Medicine, Greece.
Critselis E; The Stavros Niarchos Foundation-Collaborative Center for Clinical Epidemiology and Outcomes Research, First and Second University Departments of Pediatrics, National and Kapodistrian University of Athens School of Medicine, Greece.
Theodoridou M; First University Department of Pediatrics, 'Aghia Sophia' Children's Hospital, National and Kapodistrian University of Athens School of Medicine, Greece.
Spoulou V; First University Department of Pediatrics, 'Aghia Sophia' Children's Hospital, National and Kapodistrian University of Athens School of Medicine, Greece.
Pokaż więcej
Źródło:
Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2015 Sep; Vol. 4 (3), pp. 260-3. Date of Electronic Publication: 2014 Jan 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Community-Acquired Infections/*epidemiology
Heptavalent Pneumococcal Conjugate Vaccine/*administration & dosage
Pneumococcal Infections/*epidemiology
Pneumococcal Infections/*prevention & control
Pneumonia/*epidemiology
Child ; Child, Preschool ; Community-Acquired Infections/prevention & control ; Diagnostic Tests, Routine ; Greece ; Heptavalent Pneumococcal Conjugate Vaccine/immunology ; Humans ; Immunogenicity, Vaccine ; Infant ; Infant, Newborn ; Pneumococcal Infections/immunology ; Pneumonia/prevention & control ; Retrospective Studies ; Tertiary Care Centers
Czasopismo naukowe
Tytuł:
Interaction of Vaccination and Reduction of Antibiotic Use Drives Unexpected Increase of Pneumococcal Meningitis.
Autorzy:
de Cellès MD; 1] Institut Pasteur, Unité de Pharmaco-Épidémiologie et Maladies Infectieuses, F-75015 Paris, France [2] INSERM, U1181, F-75015 Paris, France [3] Univ. Pierre et Marie Curie, Cellule Pasteur UPMC, F-75005 Paris, France [4] Univ. Versailles Saint Quentin, UFR des Sciences de la Santé Simone-Veil, EA 4499, F-78180 Montigny-le-Bretonneux, France.
Pons-Salort M; 1] Institut Pasteur, Unité de Pharmaco-Épidémiologie et Maladies Infectieuses, F-75015 Paris, France [2] INSERM, U1181, F-75015 Paris, France [3] Univ. Pierre et Marie Curie, Cellule Pasteur UPMC, F-75005 Paris, France [4] Univ. Versailles Saint Quentin, UFR des Sciences de la Santé Simone-Veil, EA 4499, F-78180 Montigny-le-Bretonneux, France.
Varon E; 1] AP-HP, Hôpital Européen Georges-Pompidou, Laboratoire de Bactériologie, F-75015 Paris, France [2] Centre National de Référence des Pneumocoques, F-75015 Paris, France.
Vibet MA; 1] Institut Pasteur, Unité de Pharmaco-Épidémiologie et Maladies Infectieuses, F-75015 Paris, France [2] INSERM, U1181, F-75015 Paris, France [3] Univ. Pierre et Marie Curie, Cellule Pasteur UPMC, F-75005 Paris, France.
Ligier C; 1] Institut Pasteur, Unité de Pharmaco-Épidémiologie et Maladies Infectieuses, F-75015 Paris, France [2] INSERM, U1181, F-75015 Paris, France [3] Univ. Versailles Saint Quentin, UFR des Sciences de la Santé Simone-Veil, EA 4499, F-78180 Montigny-le-Bretonneux, France.
Letort V; cole Centrale Paris, Laboratoire de Mathématiques Appliquées aux Systèmes, F-92290 Châtenay-Malabry, France.
Opatowski L; 1] Institut Pasteur, Unité de Pharmaco-Épidémiologie et Maladies Infectieuses, F-75015 Paris, France [2] INSERM, U1181, F-75015 Paris, France [3] Univ. Versailles Saint Quentin, UFR des Sciences de la Santé Simone-Veil, EA 4499, F-78180 Montigny-le-Bretonneux, France.
Guillemot D; 1] Institut Pasteur, Unité de Pharmaco-Épidémiologie et Maladies Infectieuses, F-75015 Paris, France [2] INSERM, U1181, F-75015 Paris, France [3] Univ. Versailles Saint Quentin, UFR des Sciences de la Santé Simone-Veil, EA 4499, F-78180 Montigny-le-Bretonneux, France [4] AP-HP, Hôpital Raymond-Poincaré, Unité Fonctionnelle de Santé Publique, F-92380 Garches, France.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2015 Jun 11; Vol. 5, pp. 11293. Date of Electronic Publication: 2015 Jun 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-Bacterial Agents/*therapeutic use
Heptavalent Pneumococcal Conjugate Vaccine/*therapeutic use
Inappropriate Prescribing/*statistics & numerical data
Meningitis, Pneumococcal/*epidemiology
Vaccination/*statistics & numerical data
France/epidemiology ; Heptavalent Pneumococcal Conjugate Vaccine/immunology ; Humans ; Meningitis, Pneumococcal/immunology ; Meningitis, Pneumococcal/transmission ; Models, Theoretical ; Penicillin Resistance ; Penicillins/therapeutic use ; Streptococcus pneumoniae/drug effects ; Streptococcus pneumoniae/immunology ; Vaccines, Conjugate/immunology ; Vaccines, Conjugate/therapeutic use
Czasopismo naukowe
Tytuł:
The serotype distribution among healthy carriers before vaccination is essential for predicting the impact of pneumococcal conjugate vaccine on invasive disease.
Autorzy:
Flasche S; London School of Hygiene and Tropical Medicine, London, United Kingdom.
Le Polain de Waroux O; London School of Hygiene and Tropical Medicine, London, United Kingdom.
O'Brien KL; International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Edmunds WJ; London School of Hygiene and Tropical Medicine, London, United Kingdom.
Pokaż więcej
Źródło:
PLoS computational biology [PLoS Comput Biol] 2015 Apr 16; Vol. 11 (4), pp. e1004173. Date of Electronic Publication: 2015 Apr 16 (Print Publication: 2015).
Typ publikacji:
Journal Article
MeSH Terms:
Heptavalent Pneumococcal Conjugate Vaccine*/administration & dosage
Heptavalent Pneumococcal Conjugate Vaccine*/immunology
Carrier State/*epidemiology
Carrier State/*microbiology
Pneumococcal Infections/*epidemiology
Pneumococcal Infections/*microbiology
Vaccination/*statistics & numerical data
Carrier State/immunology ; Carrier State/prevention & control ; Computational Biology ; Humans ; Models, Biological ; Pneumococcal Infections/immunology ; Pneumococcal Infections/prevention & control ; Reproducibility of Results
Czasopismo naukowe
Tytuł:
Early clinical predictors for the prognosis of invasive pneumococcal disease.
Autorzy:
Wu S; Pediatric Intensive Care Unit, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
Guo X; Pediatric Intensive Care Unit, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
Xu Z; Pediatric Intensive Care Unit, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
Han M; Pediatric Intensive Care Unit, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
Huang L; Laboratory department, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
Tao Y; Laboratory department, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
Li Y; Pediatric Intensive Care Unit, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
Li Y; Nephrology department, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
Zhang T; Key Laboratory of Public Health Safety, Ministry of Education-department of Epidemiology, School of Public Health, Fudan University, Shanghai, China.
Bai Z; Pediatric Intensive Care Unit, Children's Hospital of Soochow University, Suzhou, Jiangsu, China. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2020 Sep 04; Vol. 20 (1), pp. 651. Date of Electronic Publication: 2020 Sep 04.
Typ publikacji:
Journal Article
MeSH Terms:
Pneumococcal Infections/*microbiology
Pneumococcal Infections/*mortality
Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Child, Preschool ; Female ; Heptavalent Pneumococcal Conjugate Vaccine/therapeutic use ; Hospital Mortality ; Humans ; Infant ; Male ; Microbial Sensitivity Tests ; Pneumococcal Infections/drug therapy ; Pneumococcal Infections/prevention & control ; Pneumococcal Vaccines/therapeutic use ; Prognosis ; Retrospective Studies ; Risk Factors ; Sepsis/microbiology ; Streptococcus pneumoniae/isolation & purification ; Vaccination Coverage
Czasopismo naukowe
Tytuł:
[Prevalence of Streptococcus pneumoniae serotype 19A before and after the introduction of the heptavalent conjugate vaccine in Mexico].
Autorzy:
Echániz-Avilés G; Instituto Nacional de Salud Pública, Cuernavaca, México.
San Román-Álvarez L; Instituto Nacional de Salud Pública, Cuernavaca, México.
Sánchez-Alemán M; Instituto Nacional de Salud Pública, Cuernavaca, México.
Carnalla-Barajas MN; Instituto Nacional de Salud Pública, Cuernavaca, México.
Soto-Noguerón A; Instituto Nacional de Salud Pública, Cuernavaca, México.
Pokaż więcej
Transliterated Title:
Prevalencia de Streptococcus pneumoniae serotipo 19A antes y después de la introducción de la vacuna conjugada heptavalente en México.
Źródło:
Salud publica de Mexico [Salud Publica Mex] 2014 May-Jun; Vol. 56 (3), pp. 266-71.
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
Heptavalent Pneumococcal Conjugate Vaccine*
Streptococcus pneumoniae/*classification
Child, Preschool ; Humans ; Infant ; Infant, Newborn ; Mexico ; Microbial Sensitivity Tests ; Pneumococcal Infections/drug therapy ; Pneumococcal Infections/prevention & control ; Serogroup ; Streptococcus pneumoniae/drug effects
Czasopismo naukowe
Tytuł:
Changes in pneumococcal carriage prevalence and factors associated with carriage in Norwegian children, four years after introduction of PCV13.
Autorzy:
Løvlie A; Division for Infection Control and Environmental Health, Norwegian Institute of Public Health (NIPH), P.o.box 222 Skøyen, 0213, Oslo, Norway. .; European Program for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden. .
Vestrheim DF; Division for Infection Control and Environmental Health, Norwegian Institute of Public Health (NIPH), P.o.box 222 Skøyen, 0213, Oslo, Norway.
Aaberge IS; Division for Infection Control and Environmental Health, Norwegian Institute of Public Health (NIPH), P.o.box 222 Skøyen, 0213, Oslo, Norway.
Steens A; Division for Infection Control and Environmental Health, Norwegian Institute of Public Health (NIPH), P.o.box 222 Skøyen, 0213, Oslo, Norway.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2020 Jan 10; Vol. 20 (1), pp. 29. Date of Electronic Publication: 2020 Jan 10.
Typ publikacji:
Journal Article
MeSH Terms:
Carrier State/*epidemiology
Carrier State/*microbiology
Immunologic Factors/*therapeutic use
Pneumococcal Vaccines/*therapeutic use
Streptococcus pneumoniae/*immunology
Carrier State/prevention & control ; Child ; Child, Preschool ; Cross-Sectional Studies ; Factor Analysis, Statistical ; Female ; Heptavalent Pneumococcal Conjugate Vaccine/therapeutic use ; Humans ; Immunization Programs/trends ; Infant ; Latex Fixation Tests ; Male ; Norway/epidemiology ; Odds Ratio ; Prevalence ; Serogroup ; Surveys and Questionnaires ; Vaccination ; Vaccines, Conjugate/therapeutic use
Czasopismo naukowe
Tytuł:
Indirect effect of 7-valent and 13-valent pneumococcal conjugated vaccines on pneumococcal pneumonia hospitalizations in elderly.
Autorzy:
Kislaya I; Departamento de Epidemiologia, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa, Portugal.; Centro de Investigação em Saúde Pública, Escola Nacional de Saúde Pública, Universidade Nova de Lisboa, Lisboa, Portugal.
Rodrigues AP; Departamento de Epidemiologia, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa, Portugal.
Sousa-Uva M; Departamento de Epidemiologia, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa, Portugal.; Centro de Investigação em Saúde Pública, Escola Nacional de Saúde Pública, Universidade Nova de Lisboa, Lisboa, Portugal.
Gómez V; Departamento de Epidemiologia, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa, Portugal.
Gonçalves P; Departamento de Doenças Infecciosas, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa, Portugal.
Froes F; Thorax Department, Centro Hospitalar Lisboa Norte, Lisboa, Portugal.
Nunes B; Departamento de Epidemiologia, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa, Portugal.; Centro de Investigação em Saúde Pública, Escola Nacional de Saúde Pública, Universidade Nova de Lisboa, Lisboa, Portugal.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Jan 16; Vol. 14 (1), pp. e0209428. Date of Electronic Publication: 2019 Jan 16 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Heptavalent Pneumococcal Conjugate Vaccine/*therapeutic use
Pneumococcal Vaccines/*therapeutic use
Pneumonia, Pneumococcal/*prevention & control
Aged ; Aged, 80 and over ; Female ; Hospitalization/statistics & numerical data ; Hospitalization/trends ; Humans ; Male ; Pneumonia, Pneumococcal/epidemiology ; Portugal/epidemiology ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Biofilm production by Haemophilus influenzae and Streptococcus pneumoniae isolated from the nasopharynx of children with acute otitis media.
Autorzy:
Vermee Q; Bactériologie, Hôpital Cochin, Université Paris Descartes, 27 rue du Faubourg Saint Jacques, 75679, Paris Cedex 14, France.
Cohen R; Association Clinique et Thérapeutique Infantile du Val de Marne (ACTIV), 94 Saint-Maur des Fossés, France.; IMRB- GRC GEMINI, Clinical Research Center (CRC), Centre Hospitalier Intercommunal de Créteil, Université Paris Est, Créteil, France.; Service de Néonatologie, Centre Hospitalier Intercommunal de Créteil, Créteil, France.
Hays C; Bactériologie, Hôpital Cochin, Université Paris Descartes, 27 rue du Faubourg Saint Jacques, 75679, Paris Cedex 14, France.
Varon E; Bactériologie, Hôpital Georges Pompidou, Université Paris Descartes, Paris, France.
Bonacorsi S; Bactériologie, Hôpital Robert Debré, Université Diderot, Paris, France.
Bechet S; Association Clinique et Thérapeutique Infantile du Val de Marne (ACTIV), 94 Saint-Maur des Fossés, France.
Thollot F; Essey les Nancy, AFPA, Paris, France.
Corrard F; Association Clinique et Thérapeutique Infantile du Val de Marne (ACTIV), 94 Saint-Maur des Fossés, France.
Poyart C; Bactériologie, Hôpital Cochin, Université Paris Descartes, 27 rue du Faubourg Saint Jacques, 75679, Paris Cedex 14, France.
Levy C; Association Clinique et Thérapeutique Infantile du Val de Marne (ACTIV), 94 Saint-Maur des Fossés, France.; IMRB- GRC GEMINI, Clinical Research Center (CRC), Centre Hospitalier Intercommunal de Créteil, Université Paris Est, Créteil, France.
Raymond J; Bactériologie, Hôpital Cochin, Université Paris Descartes, 27 rue du Faubourg Saint Jacques, 75679, Paris Cedex 14, France. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2019 Jan 11; Vol. 19 (1), pp. 44. Date of Electronic Publication: 2019 Jan 11.
Typ publikacji:
Journal Article
MeSH Terms:
Biofilms/*growth & development
Haemophilus influenzae/*physiology
Nasopharynx/*microbiology
Otitis Media/*microbiology
Streptococcus pneumoniae/*physiology
Child, Preschool ; Haemophilus Infections/microbiology ; Haemophilus influenzae/drug effects ; Haemophilus influenzae/isolation & purification ; Heptavalent Pneumococcal Conjugate Vaccine/therapeutic use ; Humans ; Microbial Sensitivity Tests ; Pneumococcal Infections/microbiology ; Pneumococcal Vaccines/therapeutic use ; Serogroup ; Streptococcus pneumoniae/drug effects ; Streptococcus pneumoniae/isolation & purification
Czasopismo naukowe
Tytuł:
Serologic response to pneumococcal vaccination in children experiencing recurrent invasive pneumococcal disease.
Autorzy:
Ingels HAS; Department of Pediatrics, Slagelse Hospital, Slagelse, Denmark. helene_.; Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Artillerivej 5, 2300, Copenhagen, DK, Denmark. helene_.
Kantsø B; Department of Microbiological Diagnostics &Virology, Statens Serum Institut, Copenhagen, Denmark.
Slotved HC; Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Artillerivej 5, 2300, Copenhagen, DK, Denmark.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2018 Aug 06; Vol. 18 (1), pp. 366. Date of Electronic Publication: 2018 Aug 06.
Typ publikacji:
Journal Article
MeSH Terms:
Pneumococcal Infections/*epidemiology
Pneumococcal Infections/*prevention & control
Pneumococcal Vaccines/*immunology
Streptococcus pneumoniae/*pathogenicity
Adolescent ; Antibodies, Bacterial/immunology ; Child ; Child, Preschool ; Denmark/epidemiology ; Heptavalent Pneumococcal Conjugate Vaccine/immunology ; Humans ; Immunization, Secondary ; Infant ; Pneumococcal Infections/immunology ; Retrospective Studies ; Serotyping ; Streptococcus pneumoniae/classification ; Streptococcus pneumoniae/immunology
Czasopismo naukowe
Tytuł:
The impact of serotype-specific vaccination on phylodynamic parameters of Streptococcus pneumoniae and the pneumococcal pan-genome.
Autorzy:
Azarian T; Center for Communicable Disease Dynamics, Department of Epidemiology, T.H. Chan School of Public Health, Harvard University; Cambridge, Massachusetts, United States of America.
Grant LR; Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; United States of America.
Arnold BJ; Center for Communicable Disease Dynamics, Department of Epidemiology, T.H. Chan School of Public Health, Harvard University; Cambridge, Massachusetts, United States of America.
Hammitt LL; Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; United States of America.
Reid R; Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; United States of America.
Santosham M; Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; United States of America.
Weatherholtz R; Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; United States of America.
Goklish N; Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; United States of America.
Thompson CM; Center for Communicable Disease Dynamics, Department of Epidemiology, T.H. Chan School of Public Health, Harvard University; Cambridge, Massachusetts, United States of America.
Bentley SD; Wellcome Trust Sanger Institute, Cambridge, United Kingdom.
O'Brien KL; Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; United States of America.
Hanage WP; Center for Communicable Disease Dynamics, Department of Epidemiology, T.H. Chan School of Public Health, Harvard University; Cambridge, Massachusetts, United States of America.
Lipsitch M; Center for Communicable Disease Dynamics, Department of Epidemiology, T.H. Chan School of Public Health, Harvard University; Cambridge, Massachusetts, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2018 Apr 04; Vol. 14 (4), pp. e1006966. Date of Electronic Publication: 2018 Apr 04 (Print Publication: 2018).
Typ publikacji:
Journal Article; Observational Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Genome, Bacterial*
Serogroup*
Heptavalent Pneumococcal Conjugate Vaccine/*administration & dosage
Pneumococcal Infections/*prevention & control
Pneumococcal Vaccines/*administration & dosage
Streptococcus pneumoniae/*immunology
Adolescent ; Adult ; Aged ; Child ; Genetics, Population ; Humans ; Middle Aged ; Nasopharynx/microbiology ; Phylogeny ; Pneumococcal Infections/epidemiology ; Pneumococcal Infections/immunology ; Pneumococcal Infections/microbiology ; Population Dynamics ; Prospective Studies ; Serotyping ; Streptococcus pneumoniae/genetics ; Vaccination ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies